Valuation: OrganiGram

Market Cap 21Cr 14Cr 13Cr 12Cr 11Cr 1.37TCr 21Cr 140.7Cr 54Cr 674.66Cr 54Cr 53Cr 2.34TCr P/E 2026 *
11.2x
P/E 2027 * 36.5x
Enterprise Value 21Cr 14Cr 13Cr 12Cr 11Cr 1.37TCr 21Cr 140.7Cr 54Cr 674.66Cr 54Cr 53Cr 2.34TCr EV / Sales 2026 *
0.61x
EV / Sales 2027 * 0.47x
Free-Float
69.76%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 15/01/2026
Director of Finance/CFO - 08/01/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 65 29/03/2018
Director/Board Member 56 17/12/2018
Director/Board Member 70 17/12/2018
Change 5-day change 1-year change 3-year change Capi.($)
-3.89%+9.83% - - 14Cr
-0.79%+0.27%+70.45%+221.61% 22Cr
0.00%+3.70%+19.15%+84.62% 12Cr
-7.00%-3.12%+38.81%-25.00% 10Cr
-7.22%-1.81%+37.53%-5.46% 9.69Cr
-0.19%+1.97%-38.36%-49.02% 5.77Cr
Average -3.18%+3.07%+25.52%+45.35% 11.78Cr
Weighted average by Cap. -2.94%+1.19%+38.74%+88.06%

Financials

2026 *2027 *
Net sales 34Cr 24Cr 21Cr 19Cr 18Cr 2.26TCr 35Cr 232.46Cr 90Cr 1.11TCr 90Cr 88Cr 3.87TCr 44Cr 31Cr 27Cr 25Cr 23Cr 2.93TCr 45Cr 301.77Cr 116.5Cr 1.45TCr 116.5Cr 113.95Cr 5.02TCr
Net income 1.89Cr 1.33Cr 1.16Cr 1.07Cr 1Cr 125.6Cr 1.93Cr 13Cr 4.99Cr 62Cr 4.99Cr 4.88Cr 215.13Cr 65.3L 45.96L 40.24L 37.15L 34.69L 43Cr 66.79L 4.47Cr 1.73Cr 21Cr 1.73Cr 1.69Cr 74Cr
Net Debt - -
Logo OrganiGram
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-